TrialActa orthopaedica2015

No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty. A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial.

Olle Muren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.